An update on the pharmacotherapeutic options and treatment strategies for systemic sclerosis.

Expert Opinion on Pharmacotherapy
Zsuzsanna H McMahan, Elizabeth R Volkmann

Abstract

Systemic sclerosis (SSc) is a multi-dimensional connective tissue disease of unknown etiology. Given the immense clinical complexity of SSc, the treatment of this condition is not standardized and considerable heterogeneity exists in SSc management approaches. The purpose of this article is to highlight novel therapeutic strategies and new medications under development for the treatment of systemic sclerosis (SSc). Herein, the authors focus primarily on recently completed clinical trials and phase 3 and 4 clinical trials of therapeutic agents that show promise in SSc. This review is organized by the clinical complications that occur in SSc, for which novel treatment strategies are under study. Combining therapies to address the individual manifestations of SSc is a cornerstone to the comprehensive management of this condition. Therapeutic strategies must take into account the organs involved, the level of disease activity in each area, and the disease stage. Controlling the complex biological network, progressive vasculopathy and fibrosis, as well as manifestations of end-organ dysfunction are all critical considerations when determining the best treatment approach for SSc.

References

Sep 1, 1994·Arthritis and Rheumatism·V D SteenT A Medsger
Jun 23, 2006·The New England Journal of Medicine·Donald P TashkinUNKNOWN Scleroderma Lung Study Research Group
Sep 2, 2006·Arthritis and Rheumatism·Micah R FisherPaul M Hassoun
Mar 3, 2007·Annals of the Rheumatic Diseases·Virginia D Steen, Thomas A Medsger
Jul 31, 2007·Annals of the Rheumatic Diseases·S I NihtyanovaC P Denton
Aug 25, 2007·American Journal of Respiratory and Critical Care Medicine·Donald P TashkinUNKNOWN Scleroderma Lung Study Research Group
Mar 11, 2008·Rheumatic Diseases Clinics of North America·Virginia D Steen
May 19, 2009·Rheumatology·Dimitrios DaoussisAndrew P Andonopoulos
Jan 4, 2012·Arthritis Care & Research·Russell SteeleUNKNOWN Canadian Scleroderma Research Group
Apr 12, 2012·Annals of the Rheumatic Diseases·Estrella Garcia GonzalezJörg H W Distler
Jan 21, 2014·Annals of the Rheumatic Diseases·Suzana JordanUNKNOWN EUSTAR Rituximab study group
Jul 25, 2014·JAMA : the Journal of the American Medical Association·Jacob M van LaarUNKNOWN EBMT/EULAR Scleroderma Study Group
May 21, 2015·Journal of Clinical Gastroenterology·Shishira BharadwajDonald F Kirby
May 23, 2015·Annals of the Rheumatic Diseases·Eric HachullaUNKNOWN SEDUCE study group
May 30, 2015·The European Respiratory Journal·Philippe HerveDenis Chemla
Jul 27, 2015·Rheumatic Diseases Clinics of North America·Elizabeth R Volkmann, Daniel E Furst
Sep 12, 2015·American Journal of Respiratory and Critical Care Medicine·Paul M HassounStephen C Mathai
Oct 20, 2015·Arthritis & Rheumatology·Matthew R LammiUNKNOWN PHAROS Investigators
Jan 26, 2016·Annals of Plastic Surgery·Francesco SegretoPaolo Persichetti
Feb 3, 2016·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Florence Gaillard-BigotJean-Luc Cracowski
May 11, 2016·JAMA : the Journal of the American Medical Association·Dinesh KhannaUNKNOWN DUAL-2 Investigators
Aug 11, 2016·The New England Journal of Medicine·Fredrick M Wigley, Nicholas A Flavahan
Nov 9, 2016·The European Respiratory Journal·Adriana StammSilvia Ulrich
Dec 13, 2016·Annals of the Rheumatic Diseases·Otylia Kowal-BieleckaUNKNOWN EUSTAR Coauthors

❮ Previous
Next ❯

Citations

Aug 18, 2021·Current Opinion in Rheumatology·Nicholas A Flavahan
Oct 11, 2021·Rheumatology and Therapy·Bo LiXuan Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Osamu Ishikawa, Kazunori Ohnishi
Current Rheumatology Reports
Jessica K Gordon, Robyn T Domsic
Autoimmunity Reviews
Cristiana AlmeidaCarlos Vasconcelos
© 2021 Meta ULC. All rights reserved